Convalescent plasma improves patient outcomes. Studies have demonstrated when convalescent plasma is given prior to the onset of critical disease in COVID-19 patients, it decreases patient’s viral load, inflammatory state, and respiratory demand and improves their outcomes with fewer fatalities. VL, viral load.